Bioinformatical analyses have recently validated the aberrant expression, prognostic values, and functions of FBXO43 in breast cancer, as well as the potential oncogenic roles of FBXO43 in gastric cancer and HCC [5,6,7,8]. The gene discussed is FBXO43; the disease is breast carcinoma.